Radioactive Seed Implants for Prostate Cancer

Introduction

PSI (permanent seed implant) is also termed brachytherapy; it is one of the very accurate types of radiation therapy performed on patients for the treatment of prostate cancer. The process entails small radioactive seeds directly implanted inside the prostate gland, which give out their dosage over time with precise targeting in destroying the malignant cells and thereby preventing the death of normal surrounding cells. The treatment is designed to target the prostate gland and, in some cases, the nearby seminal vesicles, with minimal impact on surrounding tissues.

What Is the Process for Implanting Radioactive Seeds?

Permanent radioactive seed implantation, also referred to as "brachytherapy" or "internal radiation therapy," is one of the most accurate and effective treatment options for prostate cancer. This procedure involves placing tiny radioactive seeds directly into the prostate gland, where they deliver a focused dose of radiation to target cancer cells while minimizing damage to nearby healthy tissue.

During the procedure, a radiation oncologist uses ultrasound to guide the implantation of radioactive seeds, typically iodine-125 (I-125), into the prostate gland. The specific number and arrangement of seeds are determined by a personalized treatment plan created using computer-generated imaging. Generally, around 100 seeds are inserted. These seeds stay in the prostate permanently and, after approximately ten months, lose their radioactive properties but remain in place. This method delivers a focused dose of radiation directly to the prostate while minimizing exposure to surrounding tissues, making it a precise and efficient treatment for prostate cancer.

Compared to external beam radiation therapy, which requires daily sessions over several weeks, brachytherapy is an outpatient procedure, typically completed in a single session. Its practicality and ability to deliver effective treatment make it a preferred option for patients with localized prostate cancer.

Who Are the Ideal Candidates for This Treatment?

Radioactive seed implantation is not suitable for all patients. It is most effective for those with localized prostate cancer that has not extended beyond the prostate or into nearby tissues. This treatment is particularly beneficial for men with low to intermediate-risk prostate cancer.

Patients with advanced prostate cancer that has spread to the bladder, rectum, or distant organs are not ideal candidates for this form of radiation therapy for prostate cancer. For these cases, other treatment options for prostate cancer, such as hormone therapy, external beam radiation therapy, or surgery, may be more appropriate.

What Are the Expected Outcomes of Radioactive Seed Implantation?

The success of radioactive seed implantation is measured primarily by reductions in prostate-specific antigen (PSA) levels after treatment. A patient’s Gleason score and PSA level at diagnosis play a critical role in predicting treatment outcomes.

Here are the five-year success rates for different risk groups:

• Low-risk prostate cancer (PSA less than 10 ng/mL and Gleason score less than 7): 95 percent success rate.

• Intermediate-risk prostate cancer (PSA less than 10 ng/mL with Gleason score of 7, or PSA 10 to 20 ng/mL with Gleason score of 6): 90 percent success rate.

• High-risk prostate cancer (PSA more than 20 ng/mL or Gleason score more than 7): 74 percent success rate.

Regular PSA monitoring is crucial to ensuring the success of the treatment. Doctors recommend PSA testing every six months after the procedure to track progress and detect any potential recurrence of cancer.

What Are the Side Effects of Prostate Cancer Radiation Therapy?

While radiation therapy for prostate cancer is generally well-tolerated, it is not without side effects. Common side effects include:

• Difficulty starting urination.

• Frequent or urgent need to urinate.

• Painful urination.

• Blood in the urine.

• Erectile dysfunction (inability to achieve or maintain erection).

• Increased bowel movement frequency or urgency.

• Blood in the stool.

These side effects of radiation for prostate cancer often diminish over time and can be managed with medications prescribed by a doctor. Talk to your healthcare provider right away about any symptoms you cannot manage.

Rare Complications:

While uncommon, some patients may experience serious complications from prostate brachytherapy, including:

• The condition makes it harder to get urine out of the body.

• The development of an abnormal passageway between the rectal wall and the outside body.

• Very few patients develop radiation-induced cancers in their bladder or rectum.

You should stay in touch with your healthcare team to find treatment for growing problems sooner.

What Are the Lifestyle Considerations After Treatment?

Patients undergoing radioactive seed implantation should follow specific guidelines for safety. For the first two months after the procedure:

• Limit close contact with small children to 20 minutes at a time.

• If a spouse or partner is pregnant, separate sleeping arrangements are necessary. Otherwise, it is safe to share a bed.

These precautions ensure that the low levels of radiation emitted by the seeds do not pose a risk to others.

What Are the Other Treatment Options for Prostate Cancer?

Radioactive seed implantation is just one of several treatment options for prostate cancer. Other methods include:

• External Beam Radiation Therapy (EBRT): A non-invasive treatment where high-energy beams target the prostate gland from outside the body.

• Radical Prostatectomy: Surgical removal of the prostate gland, often recommended for younger patients with localized cancer.

• Hormone Therapy: Used to reduce the levels of male hormones (androgens) that fuel prostate cancer growth.

• Active Surveillance: Constant medical exams work better than fast action for men with slow-moving and low-risk prostate cancer.

When prostate cancer proves slow-moving and low-risk, doctors can watch it closely without starting treatment quickly. The right treatment depends on how severe the cancer is and how it affects the patient's health condition and personal choices.

Conclusion

The use of radioactive seed treatment offers both simple and successful ways to control localized prostate cancer. Focused radiation targeting the prostate protects healthy tissue better and brings good outcomes to most patients. Long-term PSA testing helps monitor how treatment benefits the patient following radioactive seed implantation. Most side effects from this treatment appear briefly and result in manageable discomfort. People who face prostate cancer treatment decisions should look at brachytherapy as an advanced method that provides good results with minimal inconvenience.

Knowing all treatment choices gives patients and their healthcare teams better ways to choose what will work best for each person's condition.